2021 AHA科学声明:急性心肌梗死合并心源性休克的介入治疗

2021-03-04 美国心脏协会 Circulation . 2021 Mar 4

2021年3月,美国心脏协会(AHA)颁布了急性心肌梗死合并心源性休克的介入治疗科学声明,对当前介入治疗的最佳实践进行了概述,并涉及了患者的综合管理,包括血压管理、抗血小板治疗等。

中文标题:

2021 AHA科学声明:急性心肌梗死合并心源性休克的介入治疗

英文标题:

Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association

发布机构:

美国心脏协会

发布日期:

2021-03-04

简要介绍:

2021年3月,美国心脏协会(AHA)颁布了急性心肌梗死合并心源性休克的介入治疗科学声明,对当前介入治疗的最佳实践进行了概述,并涉及了患者的综合管理,包括血压管理、抗血小板治疗等。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 AHA科学声明:急性心肌梗死合并心源性休克的介入治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=988f41c002080606, title=2021 AHA科学声明:急性心肌梗死合并心源性休克的介入治疗, enTitle=Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association, guiderFrom=Circulation . 2021 Mar 4, authorId=0, author=, summary=2021年3月,美国心脏协会(AHA)颁布了急性心肌梗死合并心源性休克的介入治疗科学声明,对当前介入治疗的最佳实践进行了概述,并涉及了患者的综合管理,包括血压管理、抗血小板治疗等。, cover=https://img.medsci.cn/2021410/1618058561879_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Thu Mar 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年3月,美国心脏协会(AHA)颁布了急性心肌梗死合并心源性休克的介入治疗科学声明,对当前介入治疗的最佳实践进行了概述,并涉及了患者的综合管理,包括血压管理、抗血小板治疗等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=678, tagName=急性心肌梗死)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=678, guiderKeyword=急性心肌梗死, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4302, appHits=398, showAppHits=0, pcHits=1046, showPcHits=3902, likes=4, shares=28, comments=17, approvalStatus=1, publishedTime=Sat Apr 10 21:09:10 CST 2021, publishedTimeString=2021-03-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 10 20:42:46 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:38:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHA科学声明:急性心肌梗死合并心源性休克的介入治疗.pdf)])
2021 AHA科学声明:急性心肌梗死合并心源性休克的介入治疗.pdf
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2022-05-14 ms2000001729622810

    不错的资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-09-28 1477308bm10(暂无昵称)

    想要学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-09-14 一生何求9527

    收获巨大

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-08-23 ms1000002003099783

    挺好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
    2021-07-31 1397ad3dm59暂无昵称

    非常不错的资料

    0

拓展阅读

新型冠状病毒肺炎防控形势下急性心肌梗死诊治流程和路径中国专家共识(第1版)

中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians) · 2020-02-12

2020 ESC-ACCA立场声明:急性心肌梗死合并心源性休克的诊断和治疗

欧洲心脏病学会(ESC,European Society of Cardiology) · 2020-03-02

2020 KSMI专家共识:急性心肌梗死的药物治疗

国外心血管相关专家小组(统称) · 2020-09-20

2020 AACA意见书:急性心肌梗死的质量指标

急性心血管保健协会(AACA,Acute Cardiovascular Care Association) · 2021-02-07

2020 AACA/ESC意见书:急性心肌梗死凝血和纤溶生物标志物

急性心血管保健协会(AACA,Acute Cardiovascular Care Association) · 2020-11-07

急性心肌梗死中医临床诊疗指南

暂未更新 · 2021-07-08